SR One Capital Management, LP
Source: SEC Form 13F · as of Mar 2026SR One Capital Management, LP holds 7 biotech & pharma companies tracked by BioSniper, totaling $474.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
7
Total value held
$474.6M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Veradermics Incorporated (MANE)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| MANEVeradermics Incorporated | 2,401,868 | $151.7M |
| ZBIOZenas BioPharma, Inc. | 5,037,854 | $98.5M |
| DSGNDesign Therapeutics, Inc. | 6,526,476 | $69.4M |
| ORICOric Pharmaceuticals, Inc. | 4,514,929 | $58.5M |
| ALMSALUMIS INC. | 1,959,896 | $43.2M |
| SPRYARS Pharmaceuticals, Inc. | 4,012,903 | $32.2M |
| ORKAOruka Therapeutics, Inc. | 430,330 | $21.1M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.